
NeuroPace Investor Relations Material
Latest events

Investor Day 2025
NeuroPace
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from NeuroPace Inc
Access all reports
NeuroPace, Inc. designs and develops devices to treat patients with refractory epilepsy. The company offers RNS System, a responsive neurostimulator device that is attached to the patient's skull, like a halo, and stimulated their brain with tiny electrical pulses. In addition, its product pipeline comprises RNS Stimulator to replace the traditional battery-powered pacemaker described above with a wireless charger; and rechargeable battery; wireless charger that eliminates the need to physically remove the device from the patient’s head in order to power up the battery; RNS Remote Monitor that enables patients to use an iPad application to indicate when they are having seizures or any other relevant symptoms; and RNS Access Manager that serves as an ingenious monitor for physicians and nurses treating patients. NeuroPace, Inc. was founded in 1997 and is headquartered in Mountain View, California.
Key slides for NeuroPace Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
NeuroPace Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
NeuroPace Inc
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
NPCE
Country
🇺🇸 United States